Adapted Physical Activity in Patients With Resected Pancreatic Cancer (APACaPOp PRODIGE-56 Study): a National Multicenter Randomized Controlled Phase II Trial

Inclusion Criteria

• •Histologically proven PDAC
• •Complete macroscopic resection (R0 or R1 resection)
• •Patients randomized within 12 weeks of surgery
• •No evidence of malignant ascites, liver metastasis, spread to other distant abdominal organs, peritoneal metastasis, spread to extra-abdominal organs
• •Sufficient recovery from the operation and fit to take part in the trial
• •Able to attend for administration of the adjuvant CT
• •ECOG PS 0-2
• •Age ≥ 18 years
• •Life expectancy \> 3 months
• •Dated and signed informed consent
• •Registration in a national health care system (CMU included).